ACTRN12623000781640已完成Unknown
Prospective, randomised, cross-over, bilateral wear, dispensing trial to assess the visual performance of prototype myopia management contact lenses in myopic, adult, contact lens wearers
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
- •Be aged at least 18 years and less than 40 years, male or female.
- •Willing to comply with the clinical trial as directed by the Investigator.
- •Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
- •Have experience with wearing contact lenses.
- •Have myopia greater than 0.75 D and no more than 6.00 D.
- •Have best-corrected visual acuity at least 6/7.5 (0.1 logMAR)
- •; Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
- •Be aged at least 18 years and less than 40 years, male or female.
- •Willing to comply with the clinical trial as directed by the Investigator.
- •Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
- •Have experience with wearing contact lenses.
- •Have myopia greater than 0.75 D and no more than 6.00 D.
- •Have best-corrected visual acuity at least 6/7.5 (0.1 logMAR)
排除标准
- •Any pre-existing ocular irritation, injury, or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses.
- •Any systemic disease that adversely affects ocular health e.g., diabetes, Graves’ disease, and auto immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjogrens syndrome, and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
- •Use of or a need for concurrent category S3 and above ocular medication at enrolment.
- •Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and / or during the clinical trial.
- •NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically while wearing study lenses.
- •Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •Previous corneal refractive surgery.
- •Contraindications to contact lens wear.
- •Known allergy or intolerance to ingredients in any of the clinical trial products.
- •Currently enrolled in another clinical trial.
- •Pregnancy at time of enrolment – verbal report sufficient.
- •; Any pre-existing ocular irritation, injury, or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses.
- •Any systemic disease that adversely affects ocular health e.g., diabetes, Graves’ disease, and auto immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjogrens syndrome, and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
- •Use of or a need for concurrent category S3 and above ocular medication at enrolment.
- •Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and / or during the clinical trial.
- •NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically while wearing study lenses.
- •Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •Previous corneal refractive surgery.
- •Contraindications to contact lens wear.
- •Known allergy or intolerance to ingredients in any of the clinical trial products.
- •Currently enrolled in another clinical trial.
- •Pregnancy at time of enrolment – verbal report sufficient.
研究者
相似试验
尚未招募
不适用
Comparative Study for the Compliance and Efficacy of Kynex and Kynex3 in Dry Eye PatientsDiseases of the eye and adnexaKCT0004912Gyeongsang National University Hospital60
终止
不适用
Contralateral myopia progression trialEye - Diseases / disorders of the eyeMyopiaACTRN12618000242224Brien Holden Vision Institute10
招募中
Unknown
A trial to assess the visual performance of novel myopia management spectacle films in short-sighted young adultsEye - Diseases / disorders of the eyeMyopiaACTRN12624000198527nthalmic Pty Ltd38
已完成
不适用
A trial to assess the visual performance of astigmatic contact lenses in young adults who are short-sightedEye - Diseases / disorders of the eyeMyopiaACTRN12620001034921nthalmic Pty Ltd31
进行中（未招募）
不适用
Prospective, randomized, open, crossover, patient preference study comparing oral immediate release and transdermal oxybutynin in overactive bladder patients•Male or female (18 – 80 years) suffering from OAB.•Symptoms of OAB as defined by:Urgency frequency =7 /week,•Urinary urgency incontinence (= 7 UIE/week),•Urodynamically proven detrusor instabilityMedDRA version: 9.1Level: LLTClassification code 10059617Term: Overactive bladderEUCTR2006-000475-16-DEJohannes Gutenberg-Universität Mainz, Urologische Klinik (ausführende Stelle), Prof. Dr. med. Thürof